▶ 調査レポート

腹部大動脈瘤薬の世界市場(~2026年)

• 英文タイトル:Global Abdominal Aortic Aneurysm Drug Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。腹部大動脈瘤薬の世界市場(~2026年) / Global Abdominal Aortic Aneurysm Drug Market Insights and Forecast to 2026 / MRC2-11QY02000資料のイメージです。• レポートコード:MRC2-11QY02000
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は腹部大動脈瘤薬のグローバル市場について調査・分析したレポートです。種類別(BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他)市場規模、用途別(病院、診療所、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別腹部大動脈瘤薬の競争状況、市場シェア
・世界の腹部大動脈瘤薬市場:種類別市場規模 2015年-2020年(BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他)
・世界の腹部大動脈瘤薬市場:種類別市場規模予測 2021年-2026年(BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他)
・世界の腹部大動脈瘤薬市場:用途別市場規模 2015年-2020年(病院、診療所、その他)
・世界の腹部大動脈瘤薬市場:用途別市場規模予測 2021年-2026年(病院、診療所、その他)
・北米の腹部大動脈瘤薬市場分析:米国、カナダ
・ヨーロッパの腹部大動脈瘤薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの腹部大動脈瘤薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の腹部大動脈瘤薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの腹部大動脈瘤薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AstraZeneca Plc、Carolus Therapeutics, Inc.、Novartis AG、Vida Therapeutics Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Abdominal Aortic Aneurysm Drug Market
The global Abdominal Aortic Aneurysm Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Abdominal Aortic Aneurysm Drug Scope and Market Size
Abdominal Aortic Aneurysm Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Abdominal Aortic Aneurysm Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Abdominal Aortic Aneurysm Drug market is segmented into
BSN-908
Canakinumab
CT-2009
Ticagrelor
Others

Segment by Application, the Abdominal Aortic Aneurysm Drug market is segmented into
Hospital
Clinic
Others

Regional and Country-level Analysis
The Abdominal Aortic Aneurysm Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Abdominal Aortic Aneurysm Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Abdominal Aortic Aneurysm Drug Market Share Analysis
Abdominal Aortic Aneurysm Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Abdominal Aortic Aneurysm Drug business, the date to enter into the Abdominal Aortic Aneurysm Drug market, Abdominal Aortic Aneurysm Drug product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca Plc
Carolus Therapeutics, Inc.
Novartis AG
Vida Therapeutics Inc.

レポート目次

1 Study Coverage
1.1 Abdominal Aortic Aneurysm Drug Product Introduction
1.2 Market Segments
1.3 Key Abdominal Aortic Aneurysm Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type
1.4.2 BSN-908
1.4.3 Canakinumab
1.4.4 CT-2009
1.4.5 Ticagrelor
1.4.6 Others
1.5 Market by Application
1.5.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Abdominal Aortic Aneurysm Drug Market Size, Estimates and Forecasts
2.1.1 Global Abdominal Aortic Aneurysm Drug Revenue 2015-2026
2.1.2 Global Abdominal Aortic Aneurysm Drug Sales 2015-2026
2.2 Global Abdominal Aortic Aneurysm Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Abdominal Aortic Aneurysm Drug Competitor Landscape by Players
3.1 Abdominal Aortic Aneurysm Drug Sales by Manufacturers
3.1.1 Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020)
3.1.2 Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Abdominal Aortic Aneurysm Drug Revenue by Manufacturers
3.2.1 Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020)
3.2.2 Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Abdominal Aortic Aneurysm Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Drug Revenue in 2019
3.2.5 Global Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Abdominal Aortic Aneurysm Drug Price by Manufacturers
3.4 Abdominal Aortic Aneurysm Drug Manufacturing Base Distribution, Product Types
3.4.1 Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Abdominal Aortic Aneurysm Drug Product Type
3.4.3 Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Abdominal Aortic Aneurysm Drug Market Size by Type (2015-2020)
4.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020)
4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020)
4.1.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Abdominal Aortic Aneurysm Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Type (2021-2026)
4.2.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Abdominal Aortic Aneurysm Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Abdominal Aortic Aneurysm Drug Market Size by Application (2015-2020)
5.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020)
5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2015-2020)
5.1.3 Abdominal Aortic Aneurysm Drug Price by Application (2015-2020)
5.2 Abdominal Aortic Aneurysm Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Abdominal Aortic Aneurysm Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Abdominal Aortic Aneurysm Drug by Country
6.1.1 North America Abdominal Aortic Aneurysm Drug Sales by Country
6.1.2 North America Abdominal Aortic Aneurysm Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
6.3 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Abdominal Aortic Aneurysm Drug by Country
7.1.1 Europe Abdominal Aortic Aneurysm Drug Sales by Country
7.1.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
7.3 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Abdominal Aortic Aneurysm Drug by Region
8.1.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region
8.1.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
8.3 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Abdominal Aortic Aneurysm Drug by Country
9.1.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Country
9.1.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
9.3 Central & South America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Abdominal Aortic Aneurysm Drug by Country
10.1.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country
10.1.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Type
10.3 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Application

11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments
11.2 Carolus Therapeutics, Inc.
11.2.1 Carolus Therapeutics, Inc. Corporation Information
11.2.2 Carolus Therapeutics, Inc. Description and Business Overview
11.2.3 Carolus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Products Offered
11.2.5 Carolus Therapeutics, Inc. Related Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Description and Business Overview
11.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Products Offered
11.3.5 Novartis AG Related Developments
11.4 Vida Therapeutics Inc.
11.4.1 Vida Therapeutics Inc. Corporation Information
11.4.2 Vida Therapeutics Inc. Description and Business Overview
11.4.3 Vida Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Products Offered
11.4.5 Vida Therapeutics Inc. Related Developments
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Description and Business Overview
11.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
11.1.5 AstraZeneca Plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Abdominal Aortic Aneurysm Drug Market Estimates and Projections by Region
12.1.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Regions 2021-2026
12.2 North America Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.2.1 North America: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.2.2 North America: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.2.3 North America: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.3.2 Europe: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Abdominal Aortic Aneurysm Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Abdominal Aortic Aneurysm Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Abdominal Aortic Aneurysm Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Abdominal Aortic Aneurysm Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Abdominal Aortic Aneurysm Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Abdominal Aortic Aneurysm Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Abdominal Aortic Aneurysm Drug Market Segments
Table 2. Ranking of Global Top Abdominal Aortic Aneurysm Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BSN-908
Table 5. Major Manufacturers of Canakinumab
Table 6. Major Manufacturers of CT-2009
Table 7. Major Manufacturers of Ticagrelor
Table 8. Major Manufacturers of Others
Table 9. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Abdominal Aortic Aneurysm Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Abdominal Aortic Aneurysm Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Abdominal Aortic Aneurysm Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Abdominal Aortic Aneurysm Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2019)
Table 18. Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Abdominal Aortic Aneurysm Drug Price (2015-2020) (USD/Pcs)
Table 21. Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Abdominal Aortic Aneurysm Drug Product Type
Table 23. Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2015-2020)
Table 27. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2015-2020)
Table 29. Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2015-2020)
Table 32. North America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 34. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 38. North America Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Table 72. AstraZeneca Plc Corporation Information
Table 73. AstraZeneca Plc Description and Major Businesses
Table 74. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AstraZeneca Plc Product
Table 76. AstraZeneca Plc Recent Development
Table 77. Carolus Therapeutics, Inc. Corporation Information
Table 78. Carolus Therapeutics, Inc. Description and Major Businesses
Table 79. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Carolus Therapeutics, Inc. Product
Table 81. Carolus Therapeutics, Inc. Recent Development
Table 82. Novartis AG Corporation Information
Table 83. Novartis AG Description and Major Businesses
Table 84. Novartis AG Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Novartis AG Product
Table 86. Novartis AG Recent Development
Table 87. Vida Therapeutics Inc. Corporation Information
Table 88. Vida Therapeutics Inc. Description and Major Businesses
Table 89. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Vida Therapeutics Inc. Product
Table 91. Vida Therapeutics Inc. Recent Development
Table 92. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Abdominal Aortic Aneurysm Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Abdominal Aortic Aneurysm Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Abdominal Aortic Aneurysm Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Abdominal Aortic Aneurysm Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Abdominal Aortic Aneurysm Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Abdominal Aortic Aneurysm Drug Players
Table 110. Abdominal Aortic Aneurysm Drug Customers List
Table 111. Abdominal Aortic Aneurysm Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Abdominal Aortic Aneurysm Drug Product Picture
Figure 2. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BSN-908 Product Picture
Figure 4. Canakinumab Product Picture
Figure 5. CT-2009 Product Picture
Figure 6. Ticagrelor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Abdominal Aortic Aneurysm Drug Report Years Considered
Figure 13. Global Abdominal Aortic Aneurysm Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Abdominal Aortic Aneurysm Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Abdominal Aortic Aneurysm Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 18. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 20. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Abdominal Aortic Aneurysm Drug Revenue in 2019
Figure 22. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2019
Figure 25. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type in 2019
Figure 27. Global Abdominal Aortic Aneurysm Drug Market Share by Price Range (2015-2020)
Figure 28. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2019
Figure 30. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application in 2019
Figure 32. North America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 35. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 41. North America Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 42. Europe Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 45. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 46. Germany Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 57. Europe Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 58. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 62. China Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 85. Asia Pacific Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 86. Latin America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 89. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 97. Latin America Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Abdominal Aortic Aneurysm Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Abdominal Aortic Aneurysm Drug Market Share by Application in 2019
Figure 110. North America Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed